Beijing Airdoc Technology Co. Ltd. Class H AI Stock Analysis
Want to see HK:2251 full AI Analyst Report?
Beijing Airdoc Technology Co. Ltd. Class H (2251) AI Stock Analysis
Beijing Airdoc Technology Co. Ltd. Class H
(HKEX:2251)
The overall score is driven primarily by a solid but unprofitable financial profile: strong revenue growth and high, improving gross margins are offset by persistent operating and net losses and ongoing negative free cash flow, leaving the business dependent on its sizable equity base. The very low leverage and strong capital cushion materially reduce financial risk and support execution time, but the path to sustainable profitability remains uncertain. Technical indicators show a stabilizing price above short-term averages yet still below longer-term trends, with neutral momentum that neither strongly supports nor undermines the investment case. Valuation is constrained by the negative P/E and lack of dividend, reflecting that investors are currently paying for prospective growth rather than established earnings.
Beijing Airdoc Technology Co. Ltd. Class H (2251) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 881.99M
- Dividend Yield
- ―
- Average Volume (3M)
- 96.47K
- Price to Earnings (P/E)
- -10.6
- Beta (1Y)
- 0.88
- Revenue Growth
- 10.67%
- EPS Growth
- 57.27%
- Country
- Hong Kong
- Employees
- 155
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Beijing Airdoc Technology Co. Ltd. Class H Business Overview & Revenue Model
Company Description
Beijing Airdoc Technology Co., Ltd. provides artificial intelligence (AI) empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally. The company offers a software as a medical device...
Beijing Airdoc Technology Co. Ltd. Class H Financial Statement Overview
Summary
Financial performance is mixed: revenue and gross margins are strong and improving, and the balance sheet is robust with high equity and very low leverage, but persistent operating and net losses and consistently negative free cash flow keep overall financial quality only slightly above average.
Income Statement
42NeutralBalance Sheet
78PositiveCash Flow
38Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.91M | 173.26M | 156.37M | 203.96M | 113.66M | 115.18M |
| Gross Profit | 104.48M | 127.33M | 86.68M | 125.13M | 55.85M | 70.24M |
| EBITDA | -18.09M | -7.51M | -256.38M | -113.36M | -159.64M | -126.73M |
| Net Income | -71.48M | -24.98M | -255.46M | -132.53M | -180.00M | -142.63M |
Balance Sheet | ||||||
| Total Assets | 1.26B | 1.31B | 1.41B | 1.68B | 1.74B | 1.89B |
| Cash, Cash Equivalents and Short-Term Investments | 680.28M | 650.73M | 774.82M | 1.14B | 1.41B | 1.78B |
| Total Debt | 26.04M | 26.93M | 31.88M | 9.37M | 8.01M | 8.20M |
| Total Liabilities | 98.59M | 88.07M | 134.86M | 127.13M | 68.59M | 74.19M |
| Stockholders Equity | 1.16B | 1.23B | 1.27B | 1.54B | 1.67B | 1.82B |
Cash Flow | ||||||
| Free Cash Flow | -10.77M | -21.09M | -167.51M | 8.02M | -392.55M | -140.11M |
| Operating Cash Flow | -11.34M | -20.03M | -165.43M | 23.37M | -380.44M | -112.09M |
| Investing Cash Flow | 12.44M | -49.99M | -11.34M | -385.14M | -154.43M | -22.01M |
| Financing Cash Flow | -27.31M | -26.55M | -33.31M | -18.53M | -17.14M | 1.55B |
Beijing Airdoc Technology Co. Ltd. Class H Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2251, the sentiment is Negative. The current price of 8.71 is below the 20-day moving average (MA) of 8.99, below the 50-day MA of 8.95, and below the 200-day MA of 10.50, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 44.72 is Neutral, neither overbought nor oversold. The STOCH value of 50.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2251.
Beijing Airdoc Technology Co. Ltd. Class H Peers Comparison
Overall Rating
HK:330976Outperform
HK:221973Outperform
HK:183369.9Neutral- HK:225151.34Neutral
HK:215844Neutral
HK:662240Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:3309 | 76Outperform | HKD 1.25B | 11.58 | 5.57% | 1.97% | 4.75% | ― |
| HK:2219 | 73Outperform | HKD 1.68B | 8.48 | 6.97% | 10.14% | 3.85% | -1.23% |
| HK:1833 | 70Neutral | HKD 11.99B | 20.61 | 4.62% | ― | 7.92% | 152.75% |
| HK:2251 | 51Neutral | HKD 882.29M | -10.57 | -5.98% | ― | 10.67% | 57.27% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:2158 | 44Neutral | HKD 2.62B | 30.01 | 1.88% | 1.72% | 16.87% | ― |
| HK:6622 | 40Underperform | HKD 1.20B | -4.85 | -14.41% | ― | 2.56% | 20.20% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2251 | Beijing Airdoc Technology Co. Ltd. Class H | 8.71 | -3.08 | -26.12% | |
| HK:1833 | Ping An Healthcare and Technology Company | 5.33 | -9.55 | -64.15% | |
| HK:2158 | Yidu Tech, Inc. | 2.32 | -2.86 | -55.26% | |
| HK:2219 | Chaoju Eye Care Holdings Ltd. | 2.39 | 0.10 | 4.14% | |
| HK:3309 | C-MER Eye Care Holdings Limited | 0.97 | -0.77 | -44.13% | |
| HK:6622 | Zhaoke Ophthalmology Ltd. | 2.17 | -1.31 | -37.64% |
Beijing Airdoc Technology Co. Ltd. Class H Corporate Events
Beijing Airdoc Swings to Interim Loss as Revenue Declines
Beijing Airdoc Technology reported unaudited interim revenue of RMB67.3 million for the six months ended 30 June 2026, down from RMB83.7 million a year earlier, while gross profit fell to RMB49.3 million from RMB64.1 million. This indicates weaker to...
Beijing Airdoc Flags Interim Loss on Heavy AI and Myopia-Business Investment
Beijing Airdoc Technology Co., Ltd. has warned investors that it expects to post a net loss of no more than RMB50 million for the first half of 2026, reversing a small profit a year earlier. The company attributes the downturn mainly to heavier spend...
Beijing Airdoc Sets August Board Meeting to Approve Interim Results and Consider Dividend
Beijing Airdoc Technology Co., Ltd. has scheduled a board meeting for 28 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider whether to recommend an interim dividend, a decision th...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 18, 2026